Labcorp Holdings Inc.
LH Healthcare Diagnostics & Research
Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024. In the quarter to June 2026, revenue grew 5.78%, EPS grew 28.4%, free cash flow fell 42.0% and total debt rose 15.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for three.
Follow LH
Labcorp Holdings Inc. (LH) P/E ratio
As of 16 October 2026, Labcorp Holdings Inc. (LH) trades at a P/E ratio of 26.2×. Over the past ten years it has ranged from 7.4× (December 2018) to 49.5× (January 2024); the current reading is higher than 77% of that period. That is below the Diagnostics & Research industry median of 35.6× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 23.8× | (7.72%) |
| FY2024 | 25.8× | (47.87%) |
| FY2023 | 49.5× | 237.41% |
| FY2022 | 14.7× | 33.53% |
| FY2021 | 11.0× | 0.17% |
| FY2020 | 11.0× | (36.48%) |
| FY2019 | 17.3× | 38.49% |
| FY2018 | 12.5× | 10.76% |
| FY2017 | 11.3× | (28.45%) |
| FY2016 | 15.7× | (35.64%) |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 23.0× | (2.04%) |
| Mar 2026 | 23.5× | (1.33%) |
| Dec 2025 | 23.8× | (14.93%) |
| Sep 2025 | 28.0× | (2.58%) |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| GH Guardant Health, Inc. compare | n/m |
| DGX Quest Diagnostics Incorporated compare | 24.6× |
| LH Labcorp Holdings Inc. | 26.2× |
| MEDP Medpace Holdings, Inc. compare | 35.6× |
| MTD Mettler-Toledo International, Inc. compare | 36.4× |
| IDXX IDEXX Laboratories, Inc. compare | 39.1× |
| ILMN Illumina, Inc. compare | 48.4× |
| RVTY Revvity Inc. compare | 72.7× |
| WAT Waters Corporation compare | 109× |
| Diagnostics & Research industry median | 35.6× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on LH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement